Database

Startups

Main Industry
Health Care
Main Product/Service
Based on its ENERGI platform, the company is developing multiple novel therapeutics including ENERGI‑F705PD (an oral therapy for Parkinson’s disease) and ENERGI‑F703DFU (a gel for diabetic foot ulcers), committed to leveraging boosted cellular ATP and ant
Founded Year
2012
Unified Business No.
53726093
Status
Active
Number of Employees
20
Total Paid-in Capital
886,580,000 (NT$)
Location of Company
Taiwan , Taipei City
Exit Status
Listing(2023)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
Energenesis Biomedical Co., Ltd., founded in 2012 and recognized as a biopharmaceutical company in 2015, leverages its proprietary ENERGI platform to enhance cellular energy and activate self‑repair mechanisms, aiming to become a rising star in Taiwan’s b



More ↓

Similar Companies